Back
TScan Therapeutics Vs. Greif Industry Stock Comparison
Sell
41
TCRX
TScan Therapeutics
Last Price:
$1.82
Seasonality Move:
-6.1%
Buy
59
GEF
Greif
Last Price:
$66.88
Seasonality Move:
0.6%
Sell
41
TScan Therapeutics (TCRX)
is a Sell
Is TScan Therapeutics a Buy, Sell or Hold?
-
The current TScan Therapeutics [TCRX] share price is $1.81. The Score for TCRX is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
-
TCRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
TCRX Stock Price Chart
What is TScan Therapeutics's stock price today?
-
The TScan Therapeutics share price today is $1.81Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TCRX is experiencing slight buying pressure.
GEF Stock Price Chart
TCRX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.4 | Buy |
Relative Strength Index (14 RSI): | 62.32 | Buy |
Chaikin Money Flow: | 12038 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.45 - 1.73) | Buy |
Bollinger Bands (100): | (1.31 - 1.83) | Buy |
GEF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 15.01 | Buy |
Relative Strength Index (14 RSI): | 58.21 | Buy |
Chaikin Money Flow: | -144827 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (63.77 - 68.01) | Buy |
Bollinger Bands (100): | (52.61 - 63.13) | Buy |
TCRX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.63 | Buy |
20-day SMA: | 1.56 | Buy |
50-day SMA: | 1.5 | Buy |
200-day SMA: | 2.76 | Sell |
8-day EMA: | 1.15 | Buy |
20-day EMA: | 0.59 | Buy |
50-day EMA: | 0.27 | Buy |
200-day EMA: | 0.07 | Buy |
GEF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 68.56 | Sell |
20-day SMA: | 66.15 | Buy |
50-day SMA: | 60.54 | Buy |
200-day SMA: | 60.86 | Buy |
8-day EMA: | 42.79 | Buy |
20-day EMA: | 22.29 | Buy |
50-day EMA: | 10 | Buy |
200-day EMA: | 2.65 | Buy |
TScan Therapeutics Earnings Growth & TCRX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.03 per share, an increase next quarter of $0.04 per share, a decrease this year of $0.11 per share, and an increase next year of $0.07 per share.
Greif Earnings Growth & GEF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.38 per share, an increase next quarter of $0.80 per share, a decrease this year of $0.13 per share, and an increase next year of $1.16 per share.
TScan Therapeutics Technical Analysis
Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
27 | 30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Greif Technical Analysis
Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
27 | 30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |